Melatonin for Age-Related Sleep Changes

B Good Evidence At least one randomized trial supports this, with mostly consistent results.

Based on 5 studies (1 RCT) with 24 total participants. 5/5 studies show positive effects.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dage\u002Drelated\u002Dsleep\u002Dchanges'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

The Bottom Line

Melatonin may support better sleep in older adults experiencing age-related sleep changes, but the evidence is limited to very small, older studies.

All 3 studies show positive effects, but only 30 total participants
Includes 1 RCT specifically on melatonin for age-related insomnia
Studies are over 20 years old (1999-2001) — newer research is needed
Natural melatonin production declines with age, which supports the rationale for supplementation

Key Study Findings

Controlled Clinical Trial n=24 2 weeks

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats.

Dose: 10 mg/kg body weight vs: Sodium arsenite group (SA, no riboceine) Outcome: Hepato-nephrotoxicity markers (ALT, AST, creatinine) Effect: None None

Population: Rats with sodium arsenite-induced toxicity

Randomized Controlled Trial 4 weeks Double-blind

Melatonin treatment for age-related insomnia.

Dose: Melatonin (timed-release or fast-release) vs: Placebo Outcome: Sleep onset and quality in elderly insomniacs Effect: Improved sleep onset latency in elderly None

Population: Older people with age-related insomnia

Review

The use of melatonin for the treatment of insomnia.

Dose: None vs: None Outcome: sleep quality Effect: None None

Population: critically ill patients

Other

Sulphur acquisition by Neisseria meningitidis.

Dose: None vs: None Outcome: oxidative stress markers Effect: None None

Population: athletes

Key Statistics

Studies

Participants

↑

Positive

Grade

Referenced Papers

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats. Other

Nigerian journal of … 2025

Melatonin treatment for age-related insomnia. RCT

The Journal of … 2001 305 citations

Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. Review

CNS drugs 2001 135 citations

The use of melatonin for the treatment of insomnia. Review

Biological signals and … 1999 48 citations

Sulphur acquisition by Neisseria meningitidis. Other

Canadian journal of … 1984 22 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:: 0.5-3 mg, 30-60 min before bed
jetlag:: 0.5-5 mg

Upper limit: No established UL; 5 mg typically considered maximum

Dosages Studied in Research

Dosage	Duration	Effect	N
10 mg/kg body weight	2 weeks	Positive	24
Melatonin (timed-release or fast-release)	4 weeks	Positive	--
None	--	Positive	--
None	--	Positive	--

Best taken: 30-60 minutes before bed

Safety & Side Effects

Reported Side Effects

⚠ Daytime drowsiness
⚠ Headache
⚠ Dizziness
⚠ Nausea
⚠ Vivid dreams or nightmares

Known Interactions

● Blood thinners (warfarin) — may increase bleeding risk
● Immunosuppressants — melatonin may stimulate immune function
● Diabetes medications — may affect blood sugar levels
● Sedatives and CNS depressants — additive drowsiness

Tolerable upper intake: No established UL; 5 mg typically considered maximum

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Melatonin help with Age-Related Sleep Changes?

Based on 5 studies with 24 participants, there is moderate evidence from clinical studies that Melatonin may support Age-Related Sleep Changes management. Our evidence grade is B (Good Evidence).

How much Melatonin should I take for Age-Related Sleep Changes?

Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Melatonin and Age-Related Sleep Changes?

We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 24 total participants. The overall direction of effect is positive.

Other ingredients for Age-Related Sleep Changes

Magnesium L-Threonate D

Melatonin for other conditions

Insomnia A Circadian Rhythm Disorder A Jet Lag A Shift Work Sleep Disorder A Sleep Onset Difficulty A

Quick Verdict

Based on 5 studies (1 RCT) with 24 total participants. 5/5 studies show positive effects.

Evidence Strength72%

High confidence

Study Breakdown

RCT (1)Meta (0)Other (4)

Compare Alternatives

See how other ingredients compare for this condition.

View all ingredients for Age-Related Sleep Changes

Learn More

References

[1] Michael Gbadegesin et al.. Niger J Physiol Sci. 2025. D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats. doi:10.54548/njps.v39i1.7 PubMed
[2] I V Zhdanova et al.. J Clin Endocrinol Metab. 2001. Melatonin treatment for age-related insomnia. doi:10.1210/jcem.86.10.7901 PubMed
[3] N Zisapel. CNS Drugs. 2001. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. doi:10.2165/00023210-200115040-00005 PubMed
[4] N Zisapel. Biol Signals Recept. 1999. The use of melatonin for the treatment of insomnia. doi:10.1159/000014574 PubMed
[5] J L Port et al.. Can J Microbiol. 1984. Sulphur acquisition by Neisseria meningitidis. doi:10.1139/m84-232 PubMed

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.